Search Results - "Milito, D A"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
  2. 2

    Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV‐1‐infected subjects by MILITO, A. DE, ALEMAN, S., MARENZI, R., SÖNNERBORG, A., D, FUCHS, ZAZZI, M., CHIODI, F.

    Published in Clinical and experimental immunology (01-03-2002)
    “…SUMMARY Plasma levels of soluble CD27 (sCD27) are elevated in diseases characterized by T cell activation and are used as a marker of immune activation. We…”
    Get full text
    Journal Article
  3. 3

    Soluble CD27 induces IgG production through activation of antigen-primed B cells by Dang, L. V. P., Nilsson, A., Ingelman-Sundberg, H., Cagigi, A., Gelinck, L. B. S., Titanji, K., De Milito, A., Grutzmeier, S., Hedlund, J., Kroon, F. P., Chiodi, F.

    Published in Journal of internal medicine (01-03-2012)
    “…  Dang LVP, Nilsson A, Ingelman‐Sundberg H, Cagigi A, Gelinck LBS, Titanji K, De Milito A, Grutzmeier S, Hedlund J, Kroon FP, Chiodi F (Karolinska Institutet,…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Low frequency of plasma nerve‐growth factor detection is associated with death of memory B lymphocytes in HIV‐1 infection by TITANJI, K., NILSSON, A., MÖRCH, C., SAMUELSSON, A., SÖNNERBORG, A., GRUTZMEIER, S., ZAZZI, M., DE MILITO, A.

    Published in Clinical and experimental immunology (01-05-2003)
    “…SUMMARY Nerve growth factor (NGF) regulates B cell activation and differentiation and is an autocrine survival factor for memory B lymphocytes. We have…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Low human immunodeficiency virus type 1 (HIV-1) DNA burden as a major cause for failure to detect HIV-1 DNA in clinical specimens by PCR by ZAZZI, M, ROMANO, L, CATUCCI, M, DE MILITO, A, ALMI, P, GONNELLI, A, RUBINO, M, VALENSIN, P. E

    Published in Journal of Clinical Microbiology (01-01-1995)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  8. 8

    Zidovudine resistance mutations and human immunodeficiency virus type 1 DNA burden : Longitudinal evaluation of six patients under treatment by ZAZZI, M, CATUCCI, M, DE MILITO, A, ROMANO, L, VENTURI, G, ALMI, P, GONNELLI, A, RUBINO, M, VALENSIN, P. E

    Published in Infection (01-11-1996)
    “…Zidovudine (ZDV) is by far the most widely used drug to counteract human immunodeficiency virus type 1 (HIV-1) infection, both in monotherapy and in…”
    Get full text
    Journal Article
  9. 9

    Increased reliability of selective PCR by using additionally mutated primers and a commercial Taq DNA polymerase enhancer by DE MILITO, A, CATUCCI, M, IANNELLI, F, ROMANO, L, ZAZZI, M, VALENSIN, P. E

    Published in Molecular biotechnology (01-04-1995)
    “…A reliable selective PCR procedure that combines the use of additionally mutated primers with the specificity-enhancing properties of a commercial preparation…”
    Get full text
    Journal Article
  10. 10

    Optimal conditions for detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction with nested primers by Zazzi, M, Romano, L, Peruzzi, F, Toneatto, S, De Milito, A, Botta, G, Valensin, P E

    Published in Molecular and cellular probes (01-12-1993)
    “…An assessment of optimal conditions for nested primer amplification of low copy number target DNA sequences was made using a human immunodeficiency virus type…”
    Get more information
    Journal Article